How to Interpret a Diffusion Capacity of the Lung for Carbon …
Mar 7, 2017 · The diffusion capacity of the lung for carbon monoxide (DLCO) is used to measure the body's ability to transfer oxygen across the alveolar-capillary membrane. [1] Internists use …
Phenotypic Shift, Varied Vasculopathy Noted in IPAH - Medscape
Jul 26, 2024 · In the current study, "a DLCO of < 45% almost perfectly identified patients with nonplexiform vasculopathy with prominent pulmonary microvascular disease," they said.
Long-COVID Patients Show Abnormal Lung Perfusion Despite …
Sep 12, 2024 · A study found abnormal lung perfusion in long-COVID patients with normal CT scans, highlighting pulmonary vascular issues. At ERS 2024, researchers call for further …
DLco, Pulmonary Hypertension, and Idiopathic Pulmonary Fibrosis
Apr 12, 2007 · Can diffusion capacity be used as a measure of pulmonary hypertension in patients with idiopathic pulmonary fibrosis?
ERS/ATS Lung Guidelines Endorse Global Lung Initiative
Nov 28, 2022 · They identify commonly applied reference equations for interpreting diffusion capacity for carbon monoxide (DLCO) and lung volumes but stop short of endorsing any one …
Preoperative Evaluation of the Lung Cancer Resection Candidate
The ERS/ESTS guidelines state that DLCO should be routinely measured during preoperative evaluation of lung resection candidates, regardless of whether the spirometric evaluation is …
Bleomycin Being Underdosed in Advanced Germ Cell Tumors?
Feb 21, 2011 · A study of bleomycin toxicity showed that asymptomatic drops in lung function scores caused 20% of bleomycin doses to be missed and 20% of patients to receive less than …
Serum IFN Score May Predict Outcome in Diffuse Cutaneous SSc
Apr 8, 2025 · Serum type I interferon scores may help identify patients with diffuse cutaneous systemic sclerosis with higher disease activity and poorer prognosis.
Upadacitinib Outperforms Mycophenolate in SSc-ILD Treatment
Jun 13, 2025 · The change in DLCO (as a percentage of the predicted value) at 52 weeks was -62.7 mL in the upadacitinib group and -93.3 mL in the mycophenolate group.
Latest on Lung Function Guidelines, Bronchodilator Testing
Dec 8, 2022 · How much has changed in bronchodilator testing guidelines? Dr Aaron Holley reviews the current literature.